Walgreens Boots Alliance Inc 's Revenue in the fiscal year 2024 $ 147,658.00 millions
Walgreens Boots Alliance Inc 's Revenue in the fiscal year 2023 $ 139,081.00 millions
Walgreens Boots Alliance Inc 's Revenue in the fiscal year 2022 $ 132,702.00 millions
Walgreens Boots Alliance Inc 's Revenue in the fiscal year 2021 $ 132,509.00 millions
Walgreens Boots Alliance Inc 's Revenue in the fiscal year 2020 $ 139,537.00 millions
WBA Revenue third quarter 2025 Y/Y Growth Comment
Walgreens Boots Alliance Inc achieved in the third quarter 2025, above Company average Revenue improvement of 7.25% year on year, to $ 38,986.00 millions.
Looking into third quarter 2025 results within Pharmacy Services & Retail Drugstore industry 6 other companies have achieved higher Revenue growth. While Walgreens Boots Alliance Inc ' s Revenue increase of 7.25% ranks overall at the positon no. 1802 in the third quarter 2025.
WBA Revenue ( Y/Y Growth %)
2025
2024
2023
2022
4th Quarter
August
-
5.99 %
9.16 %
10.4 %
3rd Quarter
May
7.25 %
2.65 %
8.64 %
-4.21 %
2nd Quarter
February
4.15 %
6.28 %
3.28 %
2.98 %
1st Quarter
November
7.49 %
9.96 %
-1.53 %
-6.63 %
FY
-
6.17 %
4.81 %
-
Financial Statements
Walgreens Boots Alliance Inc 's third quarter 2025 Revenue
Walgreens Boots Alliance Inc achieved in the III. Quarter 2025 above company average sequential Revenue growth of 1.03%, to $ 38,986.00 millions, from $38,589.00 millions in the second quarter. WBA is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Pharmacy Services & Retail Drugstore industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Walgreens Boots Alliance Inc 's Revenue growth quarter on quarter, overall rank is 2685.
Walgreens Boots Alliance Inc achieved in the III. Quarter 2025 above company average sequential Revenue growth of 1.03%, to $ 38,986.00 millions, from $38,589.00 millions in the second quarter. WBA is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Pharmacy Services & Retail Drugstore industry 10 other companies have achieved higher Revenue quarter on quarter growth. While Walgreens Boots Alliance Inc 's Revenue growth quarter on quarter, overall rank is 2685.
Walgreens Boots Alliance Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (May 31 2025)
12 Months Ending (Feb 28 2025)
12 Months Ending (Nov 30 2024)
12 Months Ending (Aug 31 2024)
12 Months Ending (May 31 2024)
Cumulative Revenue 12 Months Ending
$ 154,579.00
$ 151,945.00
$ 150,409.00
$ 147,658.00
$ 145,535.00
Y / Y Revenue Growth (TTM)
6.21 %
5.08 %
5.62 %
6.17 %
6.93 %
Year on Year Revenue Growth Overall
Ranking
# 1578
# 7
# 731
# 24
# 2102
Seqeuential Revenue Change (TTM)
1.73 %
1.02 %
1.86 %
1.46 %
0.65 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2386
# 1595
# 1514
# 1528
# 2372
Cumulative Revenue growth Comment
Although Walgreens Boots Alliance Inc 's Annual Revenue growth year on year were below company's average 6.7% , Revenue announced in the May 31 2025 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 6.21% year on year, from 5.08% in Feb 28 2025.
In the Retail sector 42 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 7 to 1578.
Although Walgreens Boots Alliance Inc 's Annual Revenue growth year on year were below company's average 6.7% , Revenue announced in the May 31 2025 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 6.21% year on year, from 5.08% in Feb 28 2025.
In the Retail sector 42 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 7 to 1578.
About Walgreens Boots Alliance Inc Revenue Growth Rates (WBA), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.